The Magazine for Sleep Professionals
Friday, August 28, 2026
Circassia Pharmaceuticals Inc. announced the launch of DUAKLIR® PRESSAIR® (aclidinium bromide and formoterol fumarate) for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).1 DUAKLIR will be available in the United States on October 21st and promoted through its dedicated COPD sales force, alongside established COPD treatment TUDORZA® (aclidinium), which […]
Today, on World Lung Day (WLD), the American Thoracic Society is united with members of the Forum of International Respiratory Societies (FIRS) and WLD partner organizations to advocate for respiratory health globally and call on policymakers to ensure that everyone has access to the services they need to improve their lung health. […]
In a new UNC School of Medicine study led by Rob Tarran, PhD, biomedical researchers show how high levels of protease enzymes in the lungs of e-cigarette users suggest they are at increased risk of developing emphysema E-cigarette “vaping” is widely assumed to be safer than cigarette smoking, but scientists […]
Walgreens announced that it has expanded the Walgreens Find Care™ platform to now include chronic care management, featuring connected devices and digital therapeutic solutions for patients with diabetes, asthma and chronic obstructive pulmonary disease (COPD). In addition, one year since launch, several new health care offerings from existing and new partners have […]
David Geoffrey Chapman, BSc, PhD, of University of Technology in Sydney, Australia, has been awarded the new ATS Foundation/ResMed Research Fellowship in Sleep-disordered Breathing and PAP Therapy. Dr. Chapman’s $100,000 award will support his research into how non-invasive ventilation (NIV) can help improve sleep for people with both obstructive sleep […]
More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of inhaling vapors, gas, dust or fumes at work, according to a joint American Thoracic Society and the European Respiratory Society statement published in the ATS’s American Journal of Respiratory and Critical Care […]
The antibiotic azithromycin may reduce treatment failure in patients hospitalized for an acute exacerbation of chronic obstructive pulmonary disease (COPD), according to a randomized, controlled trial published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Azithromycin during Acute COPD Exacerbations Requiring Hospitalization (BACE): a Multicenter, Randomized, […]
In terms of first-in-class (FIC) product innovation, the Chronic Obstructive Pulmonary Disease(COPD) pipeline is lagging behind the asthma pipeline, says GlobalData, a leading data and analytics company. The company’s latest report, ‘Asthma and Chronic Obstructive Pulmonary Disease: Asthma Ahead of COPD in Terms of Innovation with the Focus on Targeted Biologic Therapies […]
Label Updated to Include Reduction in Exacerbations and Major Adverse Cardiovascular Event Safety Data in Cardiovascular-Risk COPD Patients Circassia Pharmaceuticals Inc. (“Circassia” or “the Company”), recently announced that the US Food and Drug Administration (FDA) added new data to the TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) Prescribing Information that includes data from […]
New research involving New York Eye and Ear Infirmary of Mount Sinai shows a link between patients with XFS and pulmonary disease. The results have been published in the February issue of Glaucoma Ophthalmology. Exfoliation syndrome is the most common recognizable cause of open-angle glaucoma worldwide. This systemic disorder is associated […]
